BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24331863)

  • 1. Ischemic heart disease in systemic inflammatory diseases. An appraisal.
    Gargiulo P; Marsico F; Parente A; Paolillo S; Cecere M; Casaretti L; Pellegrino AM; Formisano T; Fabiani I; Soricelli A; Trimarco B; Perrone-Filardi P
    Int J Cardiol; 2014 Jan; 170(3):286-90. PubMed ID: 24331863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiovascular risk in systemic inflammatory diseases].
    Marsico F; Parente A; Paolillo S; Casaretti L; Lo Iudice F; Pirozzi E; Conte S; Iardino E; Gambardella F; Della Ratta GL; Cirillo A; Vitagliano A; Filardi PP
    G Ital Cardiol (Rome); 2013; 14(7-8):517-25. PubMed ID: 23877549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings.
    Zinger H; Sherer Y; Shoenfeld Y
    Clin Rev Allergy Immunol; 2009 Aug; 37(1):20-8. PubMed ID: 18991025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated atherosclerosis in autoimmune rheumatic diseases.
    Shoenfeld Y; Gerli R; Doria A; Matsuura E; Cerinic MM; Ronda N; Jara LJ; Abu-Shakra M; Meroni PL; Sherer Y
    Circulation; 2005 Nov; 112(21):3337-47. PubMed ID: 16301360
    [No Abstract]   [Full Text] [Related]  

  • 5. Atherosclerotic vascular disease in the autoimmune rheumatologic patient.
    Mankad R
    Curr Atheroscler Rep; 2015 Apr; 17(4):497. PubMed ID: 25721102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of disease: atherosclerosis in autoimmune diseases.
    Sherer Y; Shoenfeld Y
    Nat Clin Pract Rheumatol; 2006 Feb; 2(2):99-106. PubMed ID: 16932663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin.
    Bartoloni E; Shoenfeld Y; Gerli R
    Arthritis Care Res (Hoboken); 2011 Feb; 63(2):178-83. PubMed ID: 20740611
    [No Abstract]   [Full Text] [Related]  

  • 8. Silent myocardial ischemia may be related to inflammatory response.
    Li JJ
    Med Hypotheses; 2004; 62(2):252-6. PubMed ID: 14962636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardiovascular manifestations of rheumatic diseases.
    Goodson NJ; Solomon DH
    Curr Opin Rheumatol; 2006 Mar; 18(2):135-40. PubMed ID: 16462518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment.
    Soltész P; Kerekes G; Dér H; Szücs G; Szántó S; Kiss E; Bodolay E; Zeher M; Timár O; Szodoray P; Szegedi G; Szekanecz Z
    Autoimmun Rev; 2011 May; 10(7):416-25. PubMed ID: 21281743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis in patients with autoimmune disorders.
    Frostegård J
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1776-85. PubMed ID: 15976324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tobacco smoking and autoimmune rheumatic diseases.
    Harel-Meir M; Sherer Y; Shoenfeld Y
    Nat Clin Pract Rheumatol; 2007 Dec; 3(12):707-15. PubMed ID: 18037930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physiopathologic relationship between interstitial cystitis and rheumatic, autoimmune, and chronic inflammatory diseases].
    Lorenzo Gómez MF; Gómez Castro S
    Arch Esp Urol; 2004; 57(1):25-34. PubMed ID: 15119315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review on anti-lipoprotein lipase antibodies.
    Rodrigues CE; Bonfá E; Carvalho JF
    Clin Chim Acta; 2010 Nov; 411(21-22):1603-5. PubMed ID: 20673827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac involvement in systemic rheumatic diseases: An update.
    Sarzi-Puttini P; Atzeni F; Gerli R; Bartoloni E; Doria A; Barskova T; Matucci-Cerinic M; Sitia S; Tomasoni L; Turiel M
    Autoimmun Rev; 2010 Oct; 9(12):849-52. PubMed ID: 20692379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia.
    Hahn BH; Grossman J; Chen W; McMahon M
    J Autoimmun; 2007; 28(2-3):69-75. PubMed ID: 17433865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Consequences of Autoimmune Rheumatic Diseases.
    Atzeni F; Nucera V; Gerratana E; Fiorenza A; Gianturco L; Corda M; Sarzi-Puttini P
    Curr Vasc Pharmacol; 2020; 18(6):566-579. PubMed ID: 31985379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women and ischemic heart disease: pathophysiologic implications from the Women's Ischemia Syndrome Evaluation (WISE) Study and future research steps.
    Quyyumi AA
    J Am Coll Cardiol; 2006 Feb; 47(3 Suppl):S66-71. PubMed ID: 16458175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-regulatory mechanisms in systemic autoimmune and rheumatic diseases.
    Nakken B; Alex P; Munthe L; Szekanecz Z; Szodoray P
    Clin Dev Immunol; 2012; 2012():957151. PubMed ID: 22474487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.